Piramal Pharma Ltd - PIRAMAL PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE0DK501011
₹ 149.50 (-0.23%) icon18 May, 2024, 12:00:00 AM
Open
₹ 150.55
Prev. Close
₹ 149.85
Turnover(lac)
₹ 0.01
Day's High
₹ 150.85
Day's Low
₹ 149.15
52 Wk High
₹ 166.70
52 Wk Low
₹ 69.97
Book Value
₹ 50.67
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 19,778.07
P/E
50.52
EPS
2.96
Div. Yield
0.00

Piramal Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/18/2024 12:00:00 AM

    ₹ 149.5 -0.35 -0.23
  • Open
  • ₹ 150.55
  • Prev. Close
  • ₹ 149.85
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 150.85
  • Day's Low
  • ₹ 149.15
  • 52 Week's High
  • ₹ 166.7
  • 52 Week's Low
  • ₹ 69.97
  • Book Value
  • ₹ 50.67
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 19,778.07
  • P/E
  • 50.52
  • EPS
  • 2.96
  • Divi. Yield
  • 0

Piramal Pharma Ltd Corporate Actions

30 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 Jan , 2024

12:00 AM

18 Oct , 2023

12:00 AM

18 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

27 Jul , 2023

12:00 AM

25 May , 2023

12:00 AM

AGM

Announcement date: 25 May , 2023

View Details

18 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Piramal Pharma Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Piramal Pharma Ltd SHAREHOLDING SNAPSHOT
20 May , 2024 | 08:52 PM

PROMOTER - TOTAL35.02%

Indian: 35.02%

Foreign: 0%

NON-PROMOTER - TOTAL 64.61%

Institutions: 42.71%

Non-Institutions: 21.89%

CUSTODIES - 0.37%

Custodies: 0.37%

See More Details
ad IconAd Image

Piramal Pharma Ltd FINANCIALS

View Profit & Loss Graph

Piramal Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Piramal Pharma Ltd

  • Nandini Piramal
  • Chairperson
  • PETER D DEYOUNG
  • Executive Director & CEO
  • Neeraj Bharadwaj
  • Director
  • Jairaj Purandare
  • Independent Director
  • S Rama Dorai
  • Independent Director
  • Peter Stevenson
  • Independent Director
  • Sridhar Gorthi
  • Independent Director
  • Vibha Paul Rishi
  • Independent Director
  • Nathalie Leitch
  • Director
  • Vivek Valsaraj
  • Executive Director & CFO
  • Tanya DCosta
  • Company Sec. & Compli. Officer

Summary

Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch. In addition, the Company has a joint venture (Allergan India Private Limited) with Allergan(now AbbVie), one of the market leaders in ophthalmology in the Indian formulations market. PPL holds 49% of the paid-up equity share capital in the joint venture. Further, PPL has a minority investment of 33.33% in Yapan Bio that operates in the biologics/ bio-therapeutics and vaccine segments. The Company is among the leading players in India in the self-care space, with established brands like Saridon, Supradyn, Lacto Calamine, Littles, Tetmosol, i-Pill and Polycrol.Apart from this, the Company offers differentiated capabilities in niches areas... Read More


Reports by Piramal Pharma Ltd


Reports by Piramal Pharma Ltd

Company FAQ

No Record Found